ACE-031

Product Description

ACE-031 is a recombinant fusion protein designed to inhibit myostatin, a negative regulator of muscle growth. It functions by binding to myostatin and related ligands, preventing their interaction with the activin type II receptor. This action allows for enhanced muscle development and reduced atrophy, making ACE-031 a key research candidate in muscular dystrophy, cachexia, and sarcopenia studies.

Benefits (Based on Preclinical Research)

• Increases skeletal muscle mass and strength

• Prevents muscle wasting in degenerative and disease models

• Supports lean tissue preservation during caloric restriction

• Reduces levels of myostatin and activin A in circulation

• Studied in Duchenne muscular dystrophy (DMD) and other myopathies

Who Uses This
Muscle physiology researchers and regenerative medicine labs use ACE-031 in studies exploring muscle wasting, neuromuscular disorders, and performance-related muscle modulation.

Why Choose ACE-031

• Potent myostatin inhibitor with high binding affinity

• Supplied in sterile, research-grade lyophilized form

• Verified by COA and independent testing

• Suitable for both short-term and long-term muscle modeling protocols

Documentation and Quality
Provided with Certificate of Analysis, purity verification via HPLC/MS, and validated handling instructions. Packaged in sterile conditions and stored under cold-chain logistics.

Disclaimer
ACE-031 is intended for laboratory research only. Not approved for human use or therapeutic treatment. Must be handled by certified professionals in authorized facilities.